Caffeine Citrate

CAS : 69-22-7

Ref. TR-C080115

Informations sur le produit

• Nom: Caffeine Citrate
• Synonymes: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, Caffeine citrate (6CI), Caffeine, citrate (1:1) (7CI,8CI), 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, mixt. contg. (9CI), Citrated caffeine, 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, mixt. contg., 1H-purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt), Cafcit, Caffeina citrate, Caffeine Citrated, Caffeine citrate, Caffeine citrate (1:1), Caffeine, citrated [USAN], Cafnea, Citrated caffein, Citric acid, compd. with caffeine (1:1), Gencebok, Peyona
• CAS: 69-22-7

Description

Applications Caffeine citrate (Cafcit) is a citrate salt of Caffeine, sometimes used in medical treatment, including short-term treatment of apnea of prematurity (lack of breathing in premature infants). Caffeine citrate functions in much the same capacity as does caffeine, but takes effect more quickly; its speed of dissociation is faster than that of Caffeine. Caffeine citrate is typically only used to treat severe migraines.
References Zubair, U.M., et al.: Anal. Profiles Drug Subs., 15, 71 (1986); Cherrah, Y., et al.: Biochem. Pharmacol., 37, 1311 (1988); Grillon, C., et al.: Clin. Neurophysiol., 114, 1557 (2003); Duangdao, D., et al.: Behav. Brain Res., 205, 1 (2009);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 386.31
• Formule: C₁₄H₁₈N₄O₉
• Couleur/Forme: White
• InChI: InChI=1S/C8H10N4O2.C6H8O7/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2, 7-3(8)1-6(13,5(11)12)2-4(9)10/h4H,1-3H3, 13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
• Code InChI: InChIKey=RCQXSQPPHJPGOF-UHFFFAOYSA-N
• SMILES: Cn1c(=O)c2c(ncn2C)n(C)c1=O.O=C(O)CC(O)(CC(=O)O)C(=O)O